Urologische Klinik


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Urethral Plate Characteristics in Cases of Non-proximal Hypospadias May Not Be Associated With a Higher Risk of Complications When a Two-Stage Repair Is Applied (2022) Marcou M, Bobbe SM, Wullich B, Hirsch-Koch K Journal article Research is an indispensable component of urology (2022) Kunath F, Burger M, Becker C Journal article, Editorial Biobanks, translational research and medical informatics (2022) Schüttler C, Jahns R, Prokosch HU, Wach S, Wullich B Journal article LACK OF CONCORDANCE BETWEEN REAL-WORLD TREATMENT PATTERNS AND CLINICAL GUIDELINE RECOMMENDATIONS FOR METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) PATIENTS (2022) Goebell P, Shah R, Raina R, Rege S, Chen S, Partridge J, Waldeck R Conference contribution Erratum zu: Viel Potenzial, wenig Substanz: Eine aktuelle Übersicht über Quantität und Qualität urologischer Apps im deutschen App-Store (2022) Mattigk A, Bellut L, Albrecht UV, von Jan U, Struck JP Journal article, Erratum Der GeSRU Guide (2022) Siech C, Neutzer M, Bellut L Journal article, Editorial Efficacy of Vinflunine for Patients with Metastatic Urothelial Cancer after Immune Checkpoint Inhibitor Pretreatment-A Retrospective Multicenter Analysis (2022) Riedel F, Muenker M, Roghmann F, Breyer J, Schnabel MJ, Burger M, Sikic D, et al. Journal article Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients (2022) Fichte A, Neumann AD, Weigelt K, Guzman J, Jansen T, Keinert J, Serrero G, et al. Journal article Reduced Recurrence Rates Are Associated with Photodynamic Diagnostics Compared to White Light after Extended Transurethral Resection of Bladder Tumors (2022) Marquardt A, Richterstetter M, Taubert H, Hartmann A, Wullich B, Lieb V, Bellut L, et al. Journal article A Prospectivly Randomized Phase-II Trial of Axitinib versus Everolimus as Second-Line Therapy in Metastatic Renal Cell Carcinoma (BERAT Study) (2022) Grünwald V, Hilser T, Meiler J, Goebell P, Ivanyi P, Strauss A, Hartmann A, et al. Journal article